Further studies on the role of phospholipids in determining the characteristics of mitochondrial binding sites for type I hexokinase.
Previous work has indicated that two types (A and B) of binding sites for hexokinase exist, but in different proportions, on brain mitochondria from various species. Hexokinase is readily solubilized from Type A sites by glucose 6-phosphate (Glc-6-P), while hexokinase bound to Type B sites remains bound even in the presence of Glc-6-P. Type A:Type B ratios are approximately 90:10, 60:40, 40:60, and 20:80 for brain mitochondria from rat, rabbit, bovine and human brain, respectively. The present study has indicated that MgCl2-dependent partitioning of mitochondrially bound hexokinase into a hydrophobic (Triton X-114) phase is generally correlated with the proportion of Type B sites. This partitioning behavior is sensitive to phospholipase C, implying that the factor(s) responsible for conferring hydrophobic character is(are) phospholipid(s). Substantial differences were also seen in the resistance of hexokinase, bound to brain mitochondria from various species, to solubilization by Triton X-100, Triton X-114, or digitonin. This resistance increased with proportion of Type B sites. Enrichment of bovine brain mitochondria in acidic phospholipids (phosphatidylserine or phosphatidylinositol), but not phosphatidylcholine or phosphatidylethanolamine, substantially increased solubilization of the enzyme after incubation at 37 degrees C. Collectively, the results imply that the Type A and Type B sites are located in membrane domains of different lipid composition, the Type A sites being in domains enriched in acidic phospholipids which lead to greater susceptibility to solubilisation by Glc-6-P.
Hutny
J
J
Department of Biochemistry, Michigan State University, East Lansing 48824-1319, USA. hutny@star.ar.wroc.pl
Wilson
J E
JE
D000818:Animals; D001665:Binding Sites; D001921:Brain / Q000378:metabolism; D002417:Cattle; D002855:Chromatography, Thin Layer; D003902:Detergents / Q000494:pharmacology; D004072:Digitonin / Q000494:pharmacology; D019298:Glucose-6-Phosphate / Q000737:chemistry; D006593:Hexokinase / Q000737:chemistry* / Q000378:metabolism*; D006801:Humans; D008274:Magnesium / Q000494:pharmacology; D008928:Mitochondria / Q000378:metabolism*; D017830:Octoxynol / Q000494:pharmacology; D010743:Phospholipids / Q000502:physiology*; D011092:Polyethylene Glycols / Q000494:pharmacology; D011485:Protein Binding; D011817:Rabbits; D051381:Rats
D003902:Detergents; D010743:Phospholipids; D011092:Polyethylene Glycols; D019298:Glucose-6-Phosphate; D017830:Octoxynol; C010615:Nonidet P-40; D006593:Hexokinase; D008274:Magnesium; D004072:Digitonin